Pipelinepharma is Media and Information Services (B2B) in Lithuania that focus on manufacturing practices business. Founded in 2010. They cover business area such as developer, pharmaceutical licensing deal, product, generic name, dossier type, good manufacturing practice, (GMP) manufacturer, business inquiry, verify dossier owner, rapid term sheet negotiation, professional support, pharmaceutical executive, less time, negotiate agreement.
Media and Information Services (B2B)
2010
( 14 years old in 2024 )
Manufacturing Practices
-
Paupio Street 28-13
Vilnius, LT-11341
Lithuania
Private
developerpharmaceutical licensing dealproductgeneric namedossier typegood manufacturing practice(GMP) manufacturerbusiness inquiryverify dossier ownerrapid term sheet negotiationprofessional supportpharmaceutical executiveless timenegotiate agreement
* We use standard office opening hours in near Pipelinepharma's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Pipelinepharma is Media and Information Services (B2B) business from Lithuania that founded in 2010 (14 years old in 2024), Pipelinepharma business is focusing on Manufacturing Practices.
Pipelinepharma headquarter office and corporate office address is located in Paupio Street 28-13 Vilnius, LT-11341 Lithuania.
Pipelinepharma was founded in Lithuania.
In 2024, Pipelinepharma is currently focus on manufacturing practices sector.
Above is snippet of Google Trends for "manufacturing practices" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Pipelinepharma, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.